Clinical study to test the effect of Manibhadra guda rasayana in psoriasis

Pre and Post Test clinical trail to assess the efficacy of manibhadra guda rasayana prayoga in psoriasis. - Manibhadra guda Rasayana prayoga

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/04/018737

Enrollment

Registered

2019-04-24

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L409- Psoriasis, unspecified

Interventions

Intervention1: Manibhadra Guda Rasayana Prayoga: Manibhadra guda ( 30 sachets) given to be consumed 1 sachet per day at bedtime for 30 days. Control Intervention1: Not applicable: Not applicable

Eligibility

Inclusion criteria

Inclusion criteria: Patients indicated for rasayana prayoga. Patients indicated for Vamana prayoga. Patients with positive biopsy report. PASI Score - moderate or less severe.

Exclusion criteria

Exclusion criteria: Mentally unsound and illiterate. Pregnant and puerperal women. Patients suffering from any chronic or systemic disease other than psoriasis. Patients who are on treatment with corticosteroids.

Design outcomes

Primary

Measure	Time frame
Subjective Parameters :- Itching / Burning Sensation. Pain - VAS scale. Objective Parameters :- PASI Score. DLQI Score. Auspitz Sign. Photograph with consent.Timepoint: Both subjective and objective parameters will be assessed at the time of admission, during the time of discharge and after 1 month of rasayana prayoga	—

Secondary

Measure	Time frame
nilTimepoint: nil	—

Countries

India

Contacts

Public ContactDr Anantharam P V

Amrita School of Ayurveda

dr.ananthramsharma@gmail.com8075850958

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026